Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000964102 | SCV001111287 | benign | not provided | 2024-10-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000964102 | SCV004128305 | likely benign | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | RERE: BP4, BP7 |
Breakthrough Genomics, |
RCV000964102 | SCV005285272 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003916145 | SCV004735855 | likely benign | RERE-related disorder | 2019-05-07 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |